# ClinicalTrials.gov record NCT02916433

> PeptideScanner retained ClinicalTrials.gov record NCT02916433 at 2026-07-30T20:21:17.072Z. Its registry update date was 2020-10-08, and PeptideScanner's reviewed identity mapping was octreotide.

- Evidence object: `story:clinicaltrials-gov-nct02916433-octreotide:v1`
- Evidence domain: Clinical trials
- Date in source: 2020-10-08
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct02916433-octreotide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct02916433-octreotide-v1.json
- Content SHA-256: `7ea78b037b95af7f04f96dd88c5431cd9f10286cd22c672af1e2d9154f04f638`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT02916433 ([`ctg-observation-nct02916433-2020-10-08-b78bd3a31500`](#source-ctg-observation-nct02916433-2020-10-08-b78bd3a31500))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT02916433 at 2026-07-30T20:21:17.072Z. Its registry update date was 2020-10-08, and PeptideScanner's reviewed identity mapping was octreotide. ([`ctg-observation-nct02916433-2020-10-08-b78bd3a31500`](#source-ctg-observation-nct02916433-2020-10-08-b78bd3a31500))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT02916433 at 2026-07-30T20:21:17.072Z. Its registry update date was 2020-10-08, and PeptideScanner's reviewed identity mapping was octreotide. ([`ctg-observation-nct02916433-2020-10-08-b78bd3a31500`](#source-ctg-observation-nct02916433-2020-10-08-b78bd3a31500))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct02916433-2020-10-08-b78bd3a31500`](#source-ctg-observation-nct02916433-2020-10-08-b78bd3a31500))

## Sources

<a id="source-ctg-observation-nct02916433-2020-10-08-b78bd3a31500"></a>
- **ClinicalTrials.gov record NCT02916433 · retained source version 2020-10-08:b78bd3a3150093f02d4e78766b0c23d361918cbd96096e9ff57b9dde426f5f4c** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT02916433) (`ctg-observation-nct02916433-2020-10-08-b78bd3a31500`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT02916433." Version 1, published 2026-08-09. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct02916433-octreotide-v1.json SHA-256: 7ea78b037b95af7f04f96dd88c5431cd9f10286cd22c672af1e2d9154f04f638.